Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2005

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to                 .

 

Commission file number: 001-14057

 

KINDRED HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   61-1323993

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

680 South Fourth Street

Louisville, KY

  40202-2412
(Address of principal executive offices)   (Zip Code)

 

(502) 596-7300

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act.)    Yes  x    No  ¨

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.    Yes  x    No  ¨

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class of Common Stock


 

Outstanding at April 30, 2005


Common stock, $0.25 par value

  38,426,884 shares

 


 

1 of 40


Table of Contents

KINDRED HEALTHCARE, INC.

FORM 10-Q

INDEX

 

         Page

PART I.

  FINANCIAL INFORMATION     

Item 1.

  Financial Statements:     
   

Condensed Consolidated Statement of Operations — for the three months ended March 31, 2005 and 2004

   3
    Condensed Consolidated Balance Sheet — March 31, 2005 and December 31, 2004    4
   

Condensed Consolidated Statement of Cash Flows — for the three months ended March 31, 2005 and 2004

   5
    Notes to Condensed Consolidated Financial Statements    6

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations    20

Item 3.

  Quantitative and Qualitative Disclosures About Market Risk    36

Item 4.

  Controls and Procedures    37

PART II.

  OTHER INFORMATION     

Item 1.

  Legal Proceedings    38

Item 6.

  Exhibits    39

 

2


Table of Contents

KINDRED HEALTHCARE, INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(Unaudited)

(In thousands, except per share amounts)

 

     Three months ended
March 31,


 
     2005

    2004

 

Revenues

   $ 939,989     $ 858,015  
    


 


Salaries, wages and benefits

     515,020       484,049  

Supplies

     128,283       115,496  

Rent

     67,996       63,619  

Other operating expenses

     152,167       142,321  

Depreciation and amortization

     24,114       21,561  

Interest expense

     2,000       3,654  

Investment income

     (2,348 )     (1,214 )
    


 


       887,232       829,486  
    


 


Income from continuing operations before reorganization items and income taxes

     52,757       28,529  

Reorganization items

     (1,371 )      
    


 


Income from continuing operations before income taxes

     54,128       28,529  

Provision for income taxes

     21,868       11,996  
    


 


Income from continuing operations

     32,260       16,533  

Income (loss) from discontinued operations, net of income taxes

     4,630       (2,693 )
    


 


Net income

   $ 36,890     $ 13,840  
    


 


Earnings per common share:

                

Basic:

                

Income from continuing operations

   $ 0.89     $ 0.47  

Income (loss) from discontinued operations

     0.13       (0.08 )
    


 


Net income

   $ 1.02     $ 0.39  
    


 


Diluted:

                

Income from continuing operations

   $ 0.73     $ 0.38  

Income (loss) from discontinued operations

     0.10       (0.06 )
    


 


Net income

   $ 0.83     $ 0.32  
    


 


Shares used in computing earnings per common share:

                

Basic

     36,312       35,414  

Diluted

     44,410       42,721  

 

See accompanying notes.

 

3


Table of Contents

KINDRED HEALTHCARE, INC.

CONDENSED CONSOLIDATED BALANCE SHEET

(Unaudited)

(In thousands, except per share amounts)

 

    

March 31,

2005


   

December 31,

2004


 
ASSETS                 

Current assets:

                

Cash and cash equivalents

   $ 15,571     $ 69,128  

Cash – restricted

     5,874       6,054  

Insurance subsidiary investments

     251,850       238,856  

Accounts receivable less allowance for loss of $65,237 – March 31, 2005 and $60,320 – December 31, 2004

     463,278       400,517  

Inventories

     36,497       35,025  

Deferred tax assets

     70,137       70,137  

Assets held for sale

     16,343       22,672  

Other

     44,286       31,954  
    


 


       903,836       874,343  

Property and equipment

     786,340       765,586  

Accumulated depreciation

     (297,629 )     (273,880 )
    


 


       488,711       491,706  

Goodwill

     41,960       31,582  

Insurance subsidiary investments

     44,442       41,651  

Deferred tax assets

     91,437       91,180  

Other

     105,884       62,831  
    


 


     $ 1,676,270     $ 1,593,293  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY                 

Current liabilities:

                

Accounts payable

   $ 111,876     $ 122,176  

Salaries, wages and other compensation

     233,999       230,056  

Due to third party payors

     23,331       33,910  

Professional liability risks

     79,115       82,609  

Other accrued liabilities

     75,340       76,985  

Income taxes

     52,068       26,748  

Long-term debt due within one year

     5,506       5,282  
    


 


       581,235       577,766  

Long-term debt

     56,304       32,544  

Professional liability risks

     203,006       204,713  

Deferred credits and other liabilities

     60,901       58,485  

Commitments and contingencies

                

Stockholders’ equity:

                

Common stock, $0.25 par value; authorized 175,000 shares; issued 38,273 shares – March 31, 2005 and 37,189 shares – December 31, 2004

     9,568       9,297  

Capital in excess of par value

     654,120       636,015  

Deferred compensation

     (7,118 )     (7,353 )

Accumulated other comprehensive income

     6       468  

Retained earnings

     118,248       81,358  
    


 


       774,824       719,785  
    


 


     $ 1,676,270     $ 1,593,293  
    


 


 

See accompanying notes.

 

4


Table of Contents

KINDRED HEALTHCARE, INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited)

(In thousands)

 

     Three months ended
March 31,


 
     2005

    2004

 

Cash flows from operating activities:

                

Net income

   $ 36,890     $ 13,840  

Adjustments to reconcile net income to net cash provided by (used in)
operating activities:

                

Depreciation and amortization

     24,114       22,046  

Amortization of deferred compensation costs

     1,912       1,743  

Provision for doubtful accounts

     4,987       8,116  

Reorganization items

     (1,371 )      

Other

     (186 )     (102 )

Change in operating assets and liabilities:

                

Accounts receivable

     (59,132 )     (54,304 )

Inventories and other assets

     (10,359 )     (9,468 )

Accounts payable

     (2,445 )     (3,184 )

Income taxes

     25,332       9,912  

Due to third party payors

     (10,579 )     (3,737 )

Other accrued liabilities

     8,791       (9,062 )
    


 


Net cash provided by (used in) operating activities

     17,954       (24,200 )
    


 


Cash flows from investing activities:

                

Purchase of property and equipment

     (17,963 )     (17,881 )

Acquisition of institutional pharmacy

     (27,600 )      

Acquisition deposit

     (31,500 )      

Sale of assets

     1,055       370  

Purchase of insurance subsidiary investments

     (113,884 )     (9,776 )

Sale of insurance subsidiary investments

     84,591       5,672  

Net change in insurance subsidiary cash and cash equivalents

     13,111       (16,820 )

Net change in other investments

           1,777  

Other

     (99 )     138  
    


 


Net cash used in investing activities

     (92,289 )     (36,520 )
    


 


Cash flows from financing activities:

                

Net change in revolving credit borrowings

     25,200       16,900  

Repayment of long-term debt

     (1,216 )     (1,032 )

Issuance of common stock

     16,699       467  

Other

     (19,905 )     (4,312 )
    


 


Net cash provided by financing activities

     20,778       12,023  
    


 


Change in cash and cash equivalents

     (53,557 )     (48,697 )

Cash and cash equivalents at beginning of period

     69,128       66,524  
    


 


Cash and cash equivalents at end of period

   $ 15,571     $ 17,827  
    


 


Supplemental information:

                

Interest payments

   $ 1,034     $ 3,272  

Income tax payments (refunds)

     (566 )     398  

 

See accompanying notes.

 

5


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 – BASIS OF PRESENTATION

 

Business

 

Kindred Healthcare, Inc. (“Kindred” or the “Company”) is a healthcare services company that through its subsidiaries operates hospitals, nursing centers, institutional pharmacies and a contract rehabilitation services business across the United States. At March 31, 2005, the Company’s hospital division operated 73 hospitals in 24 states. The Company’s health services division operated 249 nursing centers in 29 states. The Company’s pharmacy division operated an institutional pharmacy business with 36 pharmacies in 23 states and a pharmacy management business servicing substantially all of the Company’s hospitals. The Company also operated a contract rehabilitation services business which began operating as a separate division on January 1, 2004.

 

During 2004 and 2003, the Company completed several transactions related to the divestiture of unprofitable hospitals, nursing centers and other healthcare businesses. For accounting purposes, the operating results of these businesses and the losses associated with these transactions have been classified as discontinued operations in the accompanying unaudited condensed consolidated statement of operations for all periods presented. Assets not sold at March 31, 2005 have been measured at the lower of carrying value or estimated fair value less costs of disposal and have been classified as held for sale in the accompanying unaudited condensed consolidated balance sheet. See Note 2.

 

In April 2001, the Company and its subsidiaries emerged from proceedings under Chapter 11 of Title 11 of the United States Code (the “Bankruptcy Code”) pursuant to the terms of the Company’s Fourth Amended Joint Plan of Reorganization (the “Plan of Reorganization”), as modified at the confirmation hearing by the United States Bankruptcy Court for the District of Delaware. In connection with its emergence, the Company changed its name to Kindred Healthcare, Inc.

 

Impact of Recent Accounting Pronouncement

 

In December 2004, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards (“SFAS”) No. 123 (revised 2004) (“SFAS 123R”), “Share-Based Payment,” which requires companies to expense the fair value of employee stock options and other forms of stock-based compensation for interim periods that begin after June 15, 2005. This requirement represents a significant change because stock option awards have not been recognized as compensation expense in the Company’s historical consolidated financial statements under Accounting Principles Board Opinion No. 25 (“APB 25”), “Accounting for Stock Issued to Employees.” SFAS 123R requires the cost of an award, based upon fair value on the date of grant, to be recognized over the period during which an employee is required to provide service in exchange for the award (usually the vesting period). The fair value of the award on the date of grant will be estimated using option pricing models. In April 2005, the Securities and Exchange Commission (the “SEC”) approved a new rule that delays the effective date of SFAS 123R for public companies until the first annual period, rather than the first interim period, that begins after June 15, 2005. The Company expects to adopt SFAS 123R on January 1, 2006 and recognize compensation expense prospectively for non-vested stock options outstanding at December 31, 2005 and for all future stock option grants.

 

Stock Option Accounting

 

As discussed above, the Company currently follows APB 25 and related interpretations in accounting for its employee stock options.

 

6


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 1 – BASIS OF PRESENTATION (Continued)

 

Stock Option Accounting (Continued)

 

Pro forma information regarding net income and earnings per share determined as if the Company had accounted for its employee stock options under the fair value method of SFAS 123 follows (in thousands, except per share amounts):

 

     Three months ended
March 31,


 
     2005

    2004

 

Net income, as reported

   $ 36,890     $ 13,840  

Adjustments:

                

Stock-based employee compensation expense included in reported net income

     1,191       1,106  

Stock-based employee compensation expense determined under fair value based method

     (2,927 )     (2,780 )
    


 


Pro forma net income

   $ 35,154     $ 12,166  
    


 


Earnings per common share:

                

As reported:

                

Basic

   $ 1.02     $ 0.39  

Diluted

   $ 0.83     $ 0.32  

Pro forma:

                

Basic

   $ 0.97     $ 0.34  

Diluted

   $ 0.77     $ 0.28  

 

Comprehensive income

 

The following table sets forth the computation of comprehensive income (in thousands):

 

     Three months ended
March 31,


     2005

    2004

Net income

   $ 36,890     $ 13,840

Net unrealized investment gains (losses), net of income taxes

     (462 )     148
    


 

Comprehensive income

   $ 36,428     $ 13,988
    


 

 

Other information

 

The accompanying unaudited condensed consolidated financial statements do not include all of the disclosures normally required by generally accepted accounting principles or those normally required in annual reports on Form 10-K. Accordingly, these financial statements should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December 31, 2004 filed with the SEC on Form 10-K.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the Company’s customary accounting practices. Management believes that financial information included herein reflects all adjustments necessary for a fair presentation of interim results and, except as otherwise disclosed, all such adjustments are of a normal and recurring nature.

 

7


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 1 – BASIS OF PRESENTATION (Continued)

 

Reclassifications

 

Certain prior period amounts have been reclassified to conform with the current period presentation. These changes did not have any impact on the Company’s financial position, results of operations or cash flows.

 

NOTE 2 – DISCONTINUED OPERATIONS

 

In accordance with SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” the divestitures discussed in Note 1 have been accounted for as discontinued operations. Accordingly, the results of operations of these businesses for all periods presented and the losses related to these divestitures have been classified as discontinued operations, net of income taxes, in the accompanying unaudited condensed consolidated statement of operations. At March 31, 2005, the Company held for sale three hospitals and one nursing center.

 

Discontinued operations for the first quarter of 2005 included a favorable pretax adjustment of $9.6 million ($5.9 million net of income taxes) resulting from a change in estimate for professional liability reserves related to the Company’s former nursing centers in Florida and Texas.

 

A summary of discontinued operations follows (in thousands):

 

     Three months ended
March 31,


 
     2005

    2004

 

Revenues

   $ 6,519     $ 29,525  
    


 


Salaries, wages and benefits

     4,465       20,045  

Supplies

     936       2,047  

Rent

     230       1,123  

Other operating expenses (income)

     (6,475 )     10,432  

Depreciation

           485  

Interest expense

           2  

Investment income

     (165 )     (230 )
    


 


       (1,009 )     33,904  
    


 


Income (loss) from operations before income taxes

     7,528       (4,379 )

Income tax provision (benefit)

     2,898       (1,686 )
    


 


Income (loss) from operations

   $ 4,630     $ (2,693 )
    


 


 

8


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 2 – DISCONTINUED OPERATIONS (Continued)

 

The following table sets forth certain discontinued operating data by business segment (in thousands):

 

     Three months ended
March 31,


 
     2005

   2004

 

Revenues:

               

Hospital division:

               

Hospitals

   $ 5,641    $ 7,531  

Ancillary services

     6      (91 )
    

  


       5,647      7,440  

Health services division

     872      22,117  

Pharmacy division

          (32 )
    

  


     $ 6,519    $ 29,525  
    

  


Operating income (loss):

               

Hospital division:

               

Hospitals

   $ 12    $ (1,767 )

Ancillary services

     6      (186 )
    

  


       18      (1,953 )

Health services division

     7,567      (1,119 )

Pharmacy division

     8      73  
    

  


     $ 7,593    $ (2,999 )
    

  


Rent:

               

Hospital division:

               

Hospitals

   $ 50    $ 413  

Ancillary services

          (5 )
    

  


       50      408  

Health services division

     180      671  

Pharmacy division

          44  
    

  


     $ 230    $ 1,123  
    

  


Depreciation:

               

Hospital division:

               

Hospitals

   $    $ 207  

Ancillary services

           
    

  


            207  

Health services division

          278  

Pharmacy division

           
    

  


     $    $ 485  
    

  


 

9


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 2 – DISCONTINUED OPERATIONS (Continued)

 

A summary of the net assets held for sale follows (in thousands):

 

     March 31,
2005


    December 31,
2004


 

Current assets:

                

Property and equipment, net

   $ 15,706     $ 18,793  

Other

     637       3,879  
    


 


       16,343       22,672  

Current liabilities (included in other accrued liabilities)

     (286 )     (1,245 )
    


 


     $ 16,057     $ 21,427  
    


 


 

NOTE 3 – REORGANIZATION ITEMS

 

Transactions related to the Plan of Reorganization have been classified separately in the accompanying unaudited condensed consolidated statement of operations. Operating results for the first quarter of 2005 included income of $1.4 million resulting from changes in estimates for accrued professional and administrative costs in connection with the completion of legal proceedings related to the Plan of Reorganization in March 2005.

 

NOTE 4 – PHARMACY ACQUISITIONS

 

On March 2, 2005, the Company acquired the assets of Pharmacy Partners, Inc. (“PPI”), an operator of two institutional pharmacies in Pennsylvania (the “PPI Acquisition”). The operating results of PPI have been included in the accompanying unaudited condensed consolidated financial statements of the Company since the date of acquisition. The transaction was financed through the use of existing cash. A preliminary summary of the PPI Acquisition follows (in thousands):

 

Fair value of assets acquired, including goodwill and other intangible assets

   $ 31,358  

Fair value of liabilities assumed

     (3,758 )
    


Net cash paid

   $ 27,600  
    


 

The purchase price of the assets acquired in the PPI Acquisition resulted from negotiations with PPI and its shareholders that were based upon both the historical and expected future cash flows of the enterprise. Goodwill recorded in connection with the PPI Acquisition aggregated $10.2 million. The purchase price also included acquired identifiable intangible assets totaling $11.3 million that will be amortized over approximately 12 years. Additional adjustments to the purchase price of up to $1.4 million may occur through September 2006 as a result of contingent consideration in accordance with the acquisition agreement.

 

On April 1, 2005, the Company acquired the assets of Skilled Care Pharmacy (the “SCP Acquisition”), an operator of two institutional pharmacies in California. In connection with the acquisition, the Company funded an acquisition deposit of $31.5 million for the SCP Acquisition on March 31, 2005. The deposit is included in other non-current assets in the accompanying unaudited condensed consolidated balance sheet at March 31, 2005.

 

10


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 5 – REVENUES

 

Revenues are recorded based upon estimated amounts due from patients and third party payors for healthcare services provided, including anticipated settlements under reimbursement agreements with Medicare, Medicaid and other third party payors.

 

A summary of revenues by payor type follows (in thousands):

 

     Three months ended
March 31,


 
     2005

    2004

 

Medicare

   $ 414,016     $ 386,824  

Medicaid

     287,389       263,721  

Private and other

     318,586       261,247  
    


 


       1,019,991       911,792  

Eliminations:

                

Rehabilitation

     (49,545 )     (36,023 )

Pharmacy

     (30,457 )     (17,754 )
    


 


       (80,002 )     (53,777 )
    


 


     $ 939,989     $ 858,015  
    


 


 

The Company recorded income of approximately $2.9 million in the first quarter of 2005 and $2.2 million in the first quarter of 2004 related to settlements of prior year hospital Medicare cost reports.

 

NOTE 6 – EARNINGS PER SHARE

 

Earnings per common share are based upon the weighted average number of common shares outstanding during the respective periods. The diluted calculation of earnings per common share for all periods includes the dilutive effect of warrants, employee stock options and non-vested restricted stock.

 

11


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 6 – EARNINGS PER SHARE (Continued)

 

A computation of earnings per common share follows (in thousands, except per share amounts):

 

     Three months ended
March 31,


 
     2005

   2004

 

Earnings:

               

Income from continuing operations

   $ 32,260    $ 16,533  

Income (loss) from discontinued operations, net of income taxes

     4,630      (2,693 )
    

  


Net income

   $ 36,890    $ 13,840  
    

  


Shares used in the computation:

               

Weighted average shares outstanding – basic computation

     36,312      35,414  

Dilutive effect of certain securities:

               

Warrants

     6,550      5,672  

Employee stock options

     985      1,091  

Non-vested restricted stock

     563      544  
    

  


Adjusted weighted average shares outstanding – diluted computation

     44,410      42,721  
    

  


Earnings per common share:

               

Basic:

               

Income from continuing operations

   $ 0.89    $ 0.47  

Income (loss) from discontinued operations

     0.13      (0.08 )
    

  


Net income

   $ 1.02    $ 0.39  
    

  


Diluted:

               

Income from continuing operations

   $ 0.73    $ 0.38  

Income (loss) from discontinued operations

     0.10      (0.06 )
    

  


Net income

   $ 0.83    $ 0.32  
    

  


 

NOTE 7 – BUSINESS SEGMENT DATA

 

The Company operates four business segments: the hospital division, the health services division, the rehabilitation division and the pharmacy division. The hospital division operates long-term acute care hospitals. The health services division operates nursing centers. The rehabilitation division provides rehabilitation services primarily to nursing centers and long-term acute care hospitals. The pharmacy division provides pharmacy services to nursing centers and other healthcare providers. The Company defines operating income as earnings before interest, income taxes, depreciation, amortization and rent. Operating income reported for each of the Company’s business segments excludes the allocation of corporate overhead.

 

On July 1, 2004, the rehabilitation division and pharmacy division began providing services to the Company’s hospital division. Internal personnel from the hospital division were transferred to the rehabilitation division and pharmacy division in conjunction with the realignment of these services (the “Hospital Services Reorganization”).

 

12


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 7 – BUSINESS SEGMENT DATA (Continued)

 

The Company identifies its segments in accordance with the aggregation provisions of SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information.” This information is consistent with information used by the Company in managing its businesses and aggregates businesses with similar economic characteristics. The information provided in Note 7 should be read in conjunction with the discussion and analysis contained in “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

The following table sets forth certain data by business segment (in thousands):

 

     Three months ended
March 31,


 
     2005

    2004

 

Revenues:

                

Hospital division

   $ 393,040     $ 343,349  

Health services division

     454,047       435,998  

Rehabilitation division

     64,947       52,699  

Pharmacy division

     107,957       79,746  
    


 


       1,019,991       911,792  

Eliminations:

                

Rehabilitation

     (49,545 )     (36,023 )

Pharmacy

     (30,457 )     (17,754 )
    


 


       (80,002 )     (53,777 )
    


 


     $ 939,989     $ 858,015  
    


 


Income from continuing operations:

                

Operating income (loss):

                

Hospital division

   $ 101,801     $ 79,687  

Health services division

     53,021       48,945  

Rehabilitation division

     9,711       8,519  

Pharmacy division

     11,454       7,609  

Corporate:

                

Overhead

     (29,115 )     (26,834 )

Insurance subsidiary

     (2,353 )     (1,777 )
    


 


       (31,468 )     (28,611 )
    


 


       144,519       116,149  

Reorganization items

     1,371        
    


 


Operating income

     145,890       116,149  

Rent

     (67,996 )     (63,619 )

Depreciation and amortization

     (24,114 )     (21,561 )

Interest, net

     348       (2,440 )
    


 


Income from continuing operations before income taxes

     54,128       28,529  

Provision for income taxes

     21,868       11,996  
    


 


     $ 32,260     $ 16,533  
    


 


 

13


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 7 – BUSINESS SEGMENT DATA (Continued)

 

     Three months ended
March 31,


     2005

   2004

Rent:

             

Hospital division

   $ 24,717    $ 22,488

Health services division

     41,486      39,799

Rehabilitation division

     800      611

Pharmacy division

     926      662

Corporate

     67      59
    

  

     $ 67,996    $ 63,619
    

  

Depreciation and amortization:

             

Hospital division

   $ 9,554    $ 8,257

Health services division

     7,822      6,615

Rehabilitation division

     54      33

Pharmacy division

     926      530

Corporate

     5,758      6,126
    

  

     $ 24,114    $ 21,561
    

  

Capital expenditures, excluding acquisitions (including discontinued operations):

             

Hospital division

   $ 8,235    $ 5,406

Health services division

     6,957      8,450

Rehabilitation division

     2      47

Pharmacy division

     1,075      773

Corporate:

             

Information systems

     1,462      2,651

Other

     232      554
    

  

     $ 17,963    $ 17,881
    

  

 

     March 31,
2005


   December 31,
2004


Assets at end of period:

             

Hospital division

   $ 551,568    $ 515,353

Health services division

     376,016      366,164

Rehabilitation division

     7,843      7,701

Pharmacy division

     128,924      60,146

Corporate

     611,919      643,929
    

  

     $ 1,676,270    $ 1,593,293
    

  

Goodwill:

             

Hospital division

   $ 30,877    $ 30,877

Pharmacy division

     11,083      705
    

  

     $ 41,960    $ 31,582
    

  

 

14


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 8 – INSURANCE RISKS

 

The Company insures a substantial portion of its professional liability risks and workers compensation risks through a wholly owned limited purpose insurance subsidiary. Provisions for loss for these risks are based upon independent actuarially determined estimates.

 

The allowance for professional liability risks includes an estimate of the expected cost to settle reported claims and an amount, based upon past experiences, for losses incurred but not reported. These liabilities are necessarily based upon estimates and, while management believes that the provision for loss is adequate, the ultimate liability may be in excess of or less than the amounts recorded. To the extent that subsequent expected ultimate claims costs vary from historical provisions for loss, future earnings will be charged or credited.

 

The provision for loss for insurance risks, including the cost of coverage maintained with unaffiliated commercial insurance carriers, follows (in thousands):

 

     Three months ended
March 31,


     2005

    2004

Professional liability:

              

Continuing operations

   $ 21,972     $ 22,410

Discontinued operations

     (9,133 )     1,879

Workers compensation:

              

Continuing operations

   $ 13,126     $ 12,341

Discontinued operations

     138       761

 

A summary of the assets and liabilities related to insurance risks included in the accompanying unaudited condensed consolidated balance sheet follows (in thousands):

 

     March 31, 2005

   December 31, 2004

    

Professional

liability


   Workers
compensation


   Total

  

Professional

liability


  

Workers

compensation


   Total

Assets:

                                         

Current:

                                         

Insurance subsidiary investments

   $ 169,846    $ 82,004    $ 251,850    $ 172,266    $ 66,590    $ 238,856

Reinsurance recoverables

     3,466           3,466      2,103           2,103
    

  

  

  

  

  

       173,312      82,004      255,316      174,369      66,590      240,959

Non-current:

                                         

Insurance subsidiary investments

     44,442           44,442      41,651           41,651

Reinsurance recoverables

     7,537           7,537      8,306           8,306

Deposits

     7,250      1,708      8,958      6,750      1,705      8,455

Other

     5      149      154      6      160      166
    

  

  

  

  

  

       59,234      1,857      61,091      56,713      1,865      58,578
    

  

  

  

  

  

     $ 232,546    $ 83,861    $ 316,407    $ 231,082    $ 68,455    $ 299,537
    

  

  

  

  

  

Liabilities:

                                         

Allowance for insurance risks:

                                         

Current

   $ 79,115    $ 24,522    $ 103,637    $ 82,609    $ 23,571    $ 106,180

Non-current

     203,006      50,565      253,571      204,713      48,724      253,437
    

  

  

  

  

  

     $ 282,121    $ 75,087    $ 357,208    $ 287,322    $ 72,295    $ 359,617
    

  

  

  

  

  

 

15


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 8 – INSURANCE RISKS (Continued)

 

Provisions for loss for professional liability risks retained by the limited purpose insurance subsidiary have been discounted based upon management’s estimate of long-term investment yields and independent actuarial estimates of claim payment patterns. The interest rate used to discount funded professional liability risks in each period presented was 5%. Amounts equal to the discounted loss provision are funded annually. The Company does not fund the portion of professional liability risks related to estimated claims that have been incurred but not reported. Accordingly, these liabilities are not discounted. If the Company did not discount any of the allowances for professional liability risks, these balances would have approximated $296.2 million at March 31, 2005 and $302.3 million at December 31, 2004.

 

Provisions for loss for workers compensation risks retained by the limited purpose insurance subsidiary are not discounted and amounts equal to the loss provision are funded annually.

 

NOTE 9 – LEASES

 

The Company leases real estate and equipment under cancelable and non-cancelable arrangements. The following table sets forth rent expense by business segment (in thousands):

 

     Three months ended
March 31,


     2005

   2004

Hospital division:

             

Buildings:

             

Ventas, Inc. (“Ventas”)

   $ 15,504    $ 14,813

Other landlords

     3,572      2,799

Equipment

     5,641      4,876
    

  

       24,717      22,488

Health services division:

             

Buildings:

             

Ventas

     30,879      29,503

Other landlords

     9,897      9,542

Equipment

     710      754
    

  

       41,486      39,799

Rehabilitation division:

             

Buildings

     15      19

Equipment

     785      592
    

  

       800      611

Pharmacy division:

             

Buildings

     777      563

Equipment

     149      99
    

  

       926      662

Corporate:

             

Buildings

     55      51

Equipment

     12      8
    

  

       67      59
    

  

     $ 67,996    $ 63,619
    

  

 

16


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 9 – LEASES (Continued)

 

Under the Plan of Reorganization, the Company assumed the original master lease agreements with Ventas and its affiliates and simultaneously amended and restated the agreements into four new master leases (the “Master Leases”). Under the Master Leases, Ventas has a right to sever properties from the existing leases in order to create additional leases, a device adopted to facilitate its financing flexibility. In such circumstances, the aggregate lease obligations remain unchanged. Ventas exercised this severance right in December 2001 with respect to Master Lease No. 1 to create a new lease of 40 nursing centers (the “CMBS Lease”) and mortgaged these properties in connection with a securitized mortgage financing. In September 2004, Ventas exercised this severance right with respect to Master Lease No. 1 to create a new lease of one hospital and seven nursing centers (“Master Lease No. 1A”). The CMBS Lease and Master Lease No. 1A are in substantially the same form as the other Master Leases with certain modifications requested by Ventas’s lenders and required to be made by the Company pursuant to the Master Leases.

 

The Master Leases, the CMBS Lease and Master Lease No. 1A are referred to collectively as, the “Master Lease Agreements.” At March 31, 2005, the Company leased from Ventas 39 long-term acute care hospitals and 186 nursing centers.

 

Ventas has a one-time option to reset the rent and the related rent escalators under each of its original Master Leases with the Company to the “Fair Market Rental” of the leased properties. Fair Market Rental is determined through an appraisal procedure set forth in the Master Leases.

 

Generally, the Master Leases provide that Ventas can initiate the rent reset procedure under each Master Lease at any time between January 20, 2006 and July 19, 2007 by delivering a notice to the Company proposing the Fair Market Rental (as described below) for the balance of the lease term (the “Reset Proposal Notice”). If the Company and Ventas are unable to reach an agreement on the Fair Market Rental within 30 days following delivery of the Reset Proposal Notice, the Company and Ventas each must select an appraiser. These two appraisers then will have ten days to select a third independent appraiser (the “Independent Appraiser”). The Independent Appraiser will have 60 days to complete its determination of Fair Market Rental and the annual rent escalator, which determination will be final and binding on the parties. Within 30 days following the Independent Appraiser’s determination, Ventas may elect to exercise its right to reset Fair Market Rental by sending the Company a final exercise notice (the “Final Exercise Notice”).

 

Alternatively, Ventas may decide not to exercise its rental reset option, in which event the rent and the existing 3 1/2% contingent annual escalator would remain at their then current levels under the Master Leases. Provided that Ventas exercises its reset right in accordance with the Master Leases, the rent reset will become effective on the later of July 19, 2006 or the date of delivery of the Reset Proposal Notice, which can be no later than July 19, 2007.

 

As a condition to exercising its rent reset right, upon delivery of the Final Exercise Notice, Ventas is required to pay the Company a reset fee equal to a prorated portion of $5 million based upon the proportion of base rent payable under the Master Lease(s) with respect to which rent is reset to the total base rent payable under all of the Master Leases.

 

“Fair Market Rental” is generally defined under the Master Leases as the amount (including escalations) that a willing tenant would pay, and a willing landlord would accept, for leasing the leased properties for the term (including renewal terms). Fair Market Rental is to be determined on the basis of certain assumptions, including (1) all leased properties are in good condition and repair (given their respective ages and prevailing healthcare industry standards with respect to what is considered good condition and repair), without any deferred maintenance (but allowing for ordinary wear and tear), (2) all leased properties are in material compliance with

 

17


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 9 – LEASES (Continued)

 

applicable laws and have all authorizations necessary for use as a nursing center or hospital, as applicable, and (3) the replacement cost of the leased properties are not determinative of Fair Market Rental. In addition, Fair Market Rental shall take into account market conditions, market levels of earnings before interest, income taxes, depreciation, amortization, rent and management fees (“EBITDARM”), the ratio of market levels of EBITDARM to market levels of rent and the actual levels of EBITDARM at the applicable leased properties, as well as historical levels of EBITDARM at the applicable leased properties (including the EBITDARM of the leased properties measured as of April 20, 2001).

 

As discussed above, under the Master Leases, Ventas has a right to sever properties from the existing leases in order to create additional leases, a device adopted to facilitate its financing flexibility. For purposes of the reset right, the additional leases are disregarded and the Fair Market Rental is determined on the four original Master Leases.

 

Additional information regarding the Master Lease Agreements is contained in the Company’s Form 10-K for the year ended December 31, 2004 and copies of the Master Lease Agreements filed with the SEC.

 

NOTE 10 – CONTINGENCIES

 

Management continually evaluates contingencies based upon the best available information. In addition, allowances for loss are provided currently for disputed items that have continuing significance, such as certain third party reimbursements and deductions that continue to be claims in current cost reports and tax returns.

 

Management believes that allowances for losses have been provided to the extent necessary and that its assessment of contingencies is reasonable.

 

Principal contingencies are described below:

 

Revenues–Certain third party payments are subject to examination by agencies administering the various programs. The Company is contesting certain issues raised in audits of prior year cost reports.

 

Professional liability risks–The Company has provided for loss for professional liability risks based upon actuarially determined estimates. Ultimate claims costs may differ from the provisions for loss. See Notes 2 and 8.

 

Guarantees of indebtedness–Letters of credit and guarantees of indebtedness approximated $5.4 million at March 31, 2005.

 

Income taxes–In November 2004, the Internal Revenue Service (the “IRS”) proposed certain adjustments to the Company’s 2000 and 2001 federal income tax returns which the Company is contesting. The principal proposed adjustment relates to the manner of reduction of the Company’s tax attributes, primarily its net operating loss carryforwards (“NOLs”), in connection with the emergence of the Company and its subsidiaries from proceedings under the Bankruptcy Code. These proposed adjustments could have the effect of substantially eliminating the Company’s NOLs.

 

Litigation–The Company is a party to certain material litigation as well as various suits and claims arising in the ordinary course of business. See Note 11.

 

Other indemnifications–In the ordinary course of business, the Company enters into contracts containing standard indemnification provisions and indemnifications specific to a transaction such as a disposal of an operating facility. These indemnifications may cover claims against employment-related matters, governmental regulations, environmental issues, and tax matters, as well as patient, third party payor, supplier and contractual relationships. Obligations under these indemnities generally would be initiated by a breach of the terms of the contract or by a third party claim or event.

 

18


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 11 – LITIGATION

 

Summary descriptions of various significant litigation follow.

 

A shareholder derivative suit entitled Thomas G. White on behalf of Vencor, Inc. and Ventas, Inc. v. W. Bruce Lunsford, et al., Case No. 98CI03669, was filed on July 2, 1998 in the Jefferson County, Kentucky, Circuit Court. The suit was brought on behalf of the Company and Ventas against certain former executive officers and directors of the Company and Ventas. The complaint alleges that the defendants damaged the Company and Ventas by engaging in violations of the securities laws, engaging in insider trading, fraud and securities fraud and damaging the reputation of the Company and Ventas. The plaintiff asserts that such actions were taken deliberately, in bad faith and constitute breaches of the defendants’ duties of loyalty and due care. The complaint alleges that certain of the Company’s and Ventas’s former executive officers during a specified time frame violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”), by, among other things, issuing to the investing public a series of false and misleading statements concerning Ventas’s then current operations and the inherent value of its common stock. The complaint further alleges that as a result of these purported false and misleading statements concerning Ventas’s revenues and successful acquisitions, the price of its common stock was artificially inflated. In particular, the complaint alleges that the defendants issued false and misleading financial statements during the first, second and third calendar quarters of 1997 which misrepresented and understated the impact that changes in Medicare reimbursement policies would have on Ventas’s core services and profitability. The complaint further alleges that the defendants issued a series of materially false statements concerning the purportedly successful integration of Ventas’s acquisitions and prospective earnings per share for 1997 and 1998, which the defendants knew lacked any reasonable basis and were not being achieved. The suit seeks unspecified damages, interest, punitive damages, reasonable attorneys’ fees, expert witness fees and other costs, and any extraordinary equitable and/or injunctive relief permitted by law or equity to assure that the Company and Ventas have an effective remedy. In October 2002, the defendants filed a motion to dismiss for failure to prosecute the case. The court granted the motion to dismiss but the plaintiff subsequently moved the court to vacate the dismissal. The defendants filed an opposition to the plaintiff’s motion to vacate the dismissal, but in August 2003 the court reinstated the lawsuit. In September 2003, the Company filed a renewed motion to dismiss, as to all defendants, based on the plaintiff’s failure to make a demand for remedy upon the appropriate board of directors. The Company also has argued that it is an improper party to this lawsuit. In March 2004, the judge who had been presiding over this lawsuit recused himself because of a possible conflict of interest. The case was then assigned to another judge, who issued an order on July 29, 2004, vacating the previous judge’s denial of the defendants’ motion to dismiss. The parties completed their briefing on the renewed motion to dismiss in January 2005 and are awaiting the court’s ruling on that motion. The Company believes that the allegations in the complaint are without merit and intends to defend this action vigorously.

 

The Company is a party to various legal actions (some of which are not insured), and regulatory and other government investigations and sanctions arising in the ordinary course of its business. The Company is unable to predict the ultimate outcome of pending litigation and regulatory and other government investigations. In addition, there can be no assurance that the U.S. Department of Justice (the “DOJ”), the Centers for Medicare and Medicaid Services (“CMS”) or other federal and state enforcement and regulatory agencies will not initiate additional investigations related to the Company’s businesses in the future, nor can there be any assurance that the resolution of any litigation or investigations, either individually or in the aggregate, would not have a material adverse effect on the Company’s financial position, results of operations and liquidity.

 

19


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Cautionary Statement

 

This Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. All statements regarding the Company’s expected future financial position, results of operations, cash flows, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities, plans and objectives of management and statements containing the words such as “anticipate,” “approximate,” “believe,” “plan,” “estimate,” “expect,” “project,” “could,” “should,” “will,” “intend,” “may” and other similar expressions, are forward-looking statements.

 

Such forward-looking statements are inherently uncertain, and stockholders and other potential investors must recognize that actual results may differ materially from the Company’s expectations as a result of a variety of factors, including, without limitation, those discussed below. Such forward-looking statements are based upon management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the Company is unable to predict or control, that may cause the Company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks, uncertainties and other factors discussed below and detailed from time to time in the Company’s filings with the SEC. Factors that may affect the Company’s plans or results include, without limitation:

 

    the Company’s ability to operate pursuant to the terms of its debt obligations and its Master Lease Agreements with Ventas,

 

    the Company’s ability to meet its rental and debt service obligations,

 

    adverse developments with respect to the Company’s results of operations or liquidity,

 

    the Company’s ability to attract and retain key executives and other healthcare personnel,

 

    increased operating costs due to shortages in qualified nurses and other healthcare personnel,

 

    the effects of healthcare reform and government regulations, interpretation of regulations and changes in the nature and enforcement of regulations governing the healthcare industry,

 

    changes in the reimbursement rates or methods of payment from third party payors, including the Medicare and Medicaid programs, changes arising from the Medicare prospective payment system for long-term acute care hospitals (“LTAC PPS”), the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (“MMA”), and potential changes in nursing center Medicare reimbursement resulting from revised resource utilization groupings (“RUGs”) payments,

 

    national and regional economic conditions, including their effect on the availability and cost of labor, materials and other services,

 

    the Company’s ability to control costs, including labor and employee benefit costs,

 

    the Company’s ability to comply with the terms of its Corporate Integrity Agreement,

 

    the Company’s ability to successfully pursue its development activities and successfully integrate new operations, including the realization of anticipated revenues, economies of scale, cost savings and productivity gains associated with such operations,

 

    the increase in the costs of defending and insuring against alleged professional liability claims and the Company’s ability to predict the estimated costs related to such claims,

 

    the Company’s ability to successfully reduce (by divestiture of operations or otherwise) its exposure to professional liability claims,

 

20


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Cautionary Statement (Continued)

 

    the Company’s ability to successfully dispose of unprofitable facilities, and

 

    the Company’s ability to ensure and maintain an effective system of internal control over financial reporting.

 

Many of these factors are beyond the Company’s control. The Company cautions investors that any forward-looking statements made by the Company are not guarantees of future performance. The Company disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

 

General

 

The business segment data in Note 7 of the accompanying Notes to Condensed Consolidated Financial Statements should be read in conjunction with the following discussion and analysis.

 

The Company is a healthcare services company that through its subsidiaries operates hospitals, nursing centers, institutional pharmacies and a contract rehabilitation services business across the United States. At March 31, 2005, the Company’s hospital division operated 73 hospitals (5,603 licensed beds) in 24 states. The Company’s health services division operated 249 nursing centers (31,973 licensed beds) in 29 states. The Company’s pharmacy division operated an institutional pharmacy business with 36 pharmacies in 23 states and a pharmacy management business servicing substantially all of the Company’s hospitals. The Company also operated a contract rehabilitation services business which began operating as a separate division on January 1, 2004.

 

On July 1, 2004, the Company completed the Hospital Services Reorganization.

 

During 2004 and 2003, the Company effected certain strategic divestitures to improve its future operating results. For accounting purposes, the operating results of these businesses and the losses associated with these transactions have been classified as discontinued operations in the accompanying unaudited condensed consolidated statement of operations for all periods presented. Assets not sold at March 31, 2005 have been measured at the lower of carrying value or estimated fair value less costs of disposal and have been classified as held for sale in the accompanying unaudited condensed consolidated balance sheet. See Note 2 of the accompanying Notes to Condensed Consolidated Financial Statements.

 

In April 2001, the Company and its subsidiaries emerged from proceedings under the Bankruptcy Code pursuant to the terms of the Plan of Reorganization.

 

Critical Accounting Policies

 

Management’s discussion and analysis of financial condition and results of operations are based upon the Company’s consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires the use of estimates and judgments that affect the reported amounts and related disclosures of commitments and contingencies. The Company relies on historical experience and on various other assumptions that management believes to be reasonable under the circumstances to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates.

 

The Company believes the following critical accounting policies, among others, affect the more significant judgments and estimates used in the preparation of its consolidated financial statements.

 

21


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Critical Accounting Policies (Continued)

 

Revenue recognition

 

The Company has agreements with third party payors that provide for payments to each of its operating divisions. These payment arrangements may be based upon prospective rates, reimbursable costs, established charges, discounted charges or per diem payments. Net patient service revenue is reported at the estimated net realizable amounts from Medicare, Medicaid, other third party payors and individual patients for services rendered. Retroactive adjustments that are likely to result from future examinations by third party payors are accrued on an estimated basis in the period the related services are rendered and adjusted as necessary in future periods based upon final settlements.

 

The Company recorded income of approximately $3 million in the first quarter of 2005 and $2 million in the first quarter of 2004 related to settlements of prior year hospital Medicare cost reports. See Note 5 of the accompanying Notes to Condensed Consolidated Financial Statements.

 

Collectibility of accounts receivable

 

Accounts receivable consist primarily of amounts due from the Medicare and Medicaid programs, other government programs, managed care health plans, commercial insurance companies and individual patients. Estimated provisions for doubtful accounts are recorded to the extent it is probable that a portion or all of a particular account will not be collected.

 

In evaluating the collectibility of accounts receivable, the Company considers a number of factors, including the age of the accounts, changes in collection patterns, the composition of patient accounts by payor type, the status of ongoing disputes with third party payors and general industry conditions. Actual collections of accounts receivable in subsequent periods may require changes in the estimated provision for loss. Changes in these estimates are charged or credited to the results of operations in the period of the change.

 

The provision for doubtful accounts totaled $5 million and $8 million in the first quarter of 2005 and 2004, respectively.

 

Allowances for insurance risks

 

The Company insures a substantial portion of its professional liability risks and workers compensation risks through a wholly owned limited purpose insurance subsidiary. Provisions for loss for these risks are based upon independent actuarially determined estimates.

 

The allowance for professional liability risks includes an estimate of the expected cost to settle reported claims and an amount, based upon past experiences, for losses incurred but not reported. These liabilities are necessarily based upon estimates and, while management believes that the provision for loss is adequate, the ultimate liability may be in excess of or less than the amounts recorded. To the extent that subsequent expected ultimate claims costs vary from historical provisions for loss, future earnings will be charged or credited.

 

Provisions for loss for professional liability risks retained by the limited purpose insurance subsidiary have been discounted based upon management’s estimate of long-term investment yields and independent actuarial estimates of claim payment patterns. The interest rate used to discount funded professional liability risks in each period presented was 5%. Amounts equal to the discounted loss provision are funded annually. The Company does not fund the portion of professional liability risks related to estimated claims that have been incurred but not reported. Accordingly, these liabilities are not discounted. The allowance for professional liability risks aggregated $282 million at March 31, 2005 and $287 million at December 31, 2004. If the Company did not discount any of the allowances for professional liability risks, these balances would have approximated $296 million at March 31, 2005 and $302 million at December 31, 2004.

 

22


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Critical Accounting Policies (Continued)

 

Allowances for insurance risks (Continued)

 

Changes in the number of professional liability claims and the increasing cost to settle these claims significantly impact the allowance for professional liability risks. A relatively small variance between the Company’s estimated and ultimate actual number of claims or average cost per claim could have a material impact, either favorable or unfavorable, on the adequacy of the allowance for professional liability risks. For example, a 1% variance in the allowance for professional liability risks at March 31, 2005 would impact the Company’s operating income by approximately $3 million. During the first quarter of 2005, the Company recorded a favorable pretax change in estimate aggregating approximately $10 million for professional liability reserves related to its former Florida and Texas nursing centers (included in discontinued operations).

 

The provision for professional liability risks (continuing operations), including the cost of coverage maintained with unaffiliated commercial insurance carriers, aggregated $22 million in the first quarter of both 2005 and 2004.

 

Provisions for loss for workers compensation risks retained by the limited purpose insurance subsidiary are not discounted and amounts equal to the loss provision are funded annually. The allowance for workers compensation risks aggregated $75 million at March 31, 2005 and $72 million at December 31, 2004. The provision for workers compensation risks, including the cost of coverage maintained with unaffiliated commercial insurance carriers, aggregated $13 million and $12 million in the first quarter of 2005 and 2004, respectively.

 

See Note 8 of the accompanying Notes to Condensed Consolidated Financial Statements.

 

Accounting for income taxes

 

The provision for income taxes is based upon the Company’s estimate of taxable income or loss for each respective accounting period. The Company recognizes an asset or liability for the deferred tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts in the financial statements. These temporary differences will result in taxable or deductible amounts in future years when the reported amounts of the assets are recovered or liabilities are settled. The Company also recognizes as deferred tax assets the future tax benefits from net operating and capital loss carryforwards. A valuation allowance is provided for these deferred tax assets if it is more likely than not that some portion or all of the net deferred tax assets will not be realized.

 

There are significant uncertainties with respect to professional liability costs and future government payments to both the Company’s hospitals and nursing centers which, among other things, could affect materially the realization of certain deferred tax assets. Accordingly, the Company has recognized deferred tax assets to the extent it is more likely than not they will be realized and a valuation allowance is provided for deferred tax assets to the extent the realizability of the deferred tax assets is uncertain. The Company recognized deferred tax assets totaling approximately $161 million at March 31, 2005 and December 31, 2004.

 

In November 2004, the IRS proposed certain adjustments to the Company’s 2000 and 2001 federal income tax returns which the Company is contesting. The principal proposed adjustment relates to the manner of reduction of the Company’s tax attributes, primarily its NOLs, in connection with the emergence of the Company and its subsidiaries from proceedings under the Bankruptcy Code. These proposed adjustments could have the effect of substantially eliminating the Company’s NOLs. However, management believes that the ultimate resolution of these issues will not have a material adverse effect on the Company’s financial position, results of operations or liquidity.

 

23


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Critical Accounting Policies (Continued)

 

Accounting for income taxes (Continued)

 

The Company is subject to various income tax audits at the federal and state levels in the ordinary course of business. Such audits could result in increased tax payments, interest and penalties. While the Company believes its tax positions are appropriate, there can be no assurance that the various authorities engaged in the examination of its income tax returns will not challenge the Company’s positions.

 

Valuation of long-lived assets and goodwill

 

The Company regularly reviews the carrying value of certain long-lived assets and the related identifiable intangible assets with respect to any events or circumstances that indicate an impairment or an adjustment to the amortization period is necessary. If circumstances suggest the recorded amounts cannot be recovered based upon estimated future undiscounted cash flows, the carrying values of such assets are reduced to fair value.

 

In assessing the carrying values of long-lived assets, the Company estimates future cash flows at the lowest level for which there are independent, identifiable cash flows. For this purpose, these cash flows are aggregated based upon the contractual agreements underlying the operation of the facility or group of facilities. Generally, an individual facility is considered the lowest level for which there are independent, identifiable cash flows. However, to the extent that groups of facilities are leased under a master lease agreement in which the operations of a facility and compliance with the lease terms are interdependent upon other facilities in the agreement (including the Company’s ability to renew the lease or divest a particular property), the Company defines the group of facilities under the master lease agreement as the lowest level for which there are independent, identifiable cash flows. Accordingly, the estimated cash flows of all facilities within a master lease agreement are aggregated for purposes of evaluating the carrying values of long-lived assets.

 

In connection with SFAS No. 142, “Goodwill and Other Intangible Assets,” the Company is required to perform an impairment test for goodwill at least annually or more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. The Company performs its annual impairment test at the end of each year. No impairment charge was recorded at December 31, 2004 in connection with the annual impairment test.

 

Recent Developments

 

Medicare payments to the Company’s nursing centers are based upon certain RUGs payment rates developed by CMS that provide various levels of reimbursement based upon patient acuity. These payment rates could be reduced in the future and may result in a substantial reduction in nursing center revenues and operating margins. The 20% upward adjustment in the payment rates for the care of higher acuity patients under the Balanced Budget Refinement Act (the “BBRA”) will remain in effect until a revised RUGs payment system is established by CMS. The White House Administration (the “Administration”) previously announced that it will delay the establishment of the revised RUG classification system until 2005. On February 7, 2005, the Administration released its budget proposal for fiscal year 2006, proposing, among other things, to proceed with the refinement of the RUGs payment system. The proposed budget estimates that RUGs refinement will result in an annual savings to Medicare of approximately $1.5 billion in fiscal year 2006 and $10.1 billion over five years. The Administration has not yet proposed a regulation to implement RUGs refinement and the Company cannot anticipate when RUGs refinement may be implemented. Nursing center revenues associated with the 20% upward adjustment approximated $10 million in the first quarter of both 2005 and 2004. Nursing center revenues associated with the 20% upward adjustment approximated $39 million, $36 million, and $33 million for the years ended December 31, 2004, 2003, and 2002, respectively.

 

24


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Recent Developments (Continued)

 

In addition, CMS recently issued proposed rules that could result in a material reduction in Medicare payments to the Company’s hospitals. On April 25, 2005, CMS published the proposed updates to the weights for diagnosis related groups (“DRGs”) and the geometric length-of-stay thresholds that are scheduled to take effect for Medicare discharges under LTAC PPS occurring on or after October 1, 2005. CMS has estimated that these proposed changes would result in an aggregate reduction in payments to long-term acute care hospitals of approximately 4.7%. Based upon its recent historical discharges, the Company has estimated that the impact of these proposed changes could reduce Medicare revenues to the Company’s hospitals between $35 million to $40 million on an annualized basis. These proposed rules are subject to a 60-day comment period. If the proposed rules were implemented, the potential reduction in Medicare revenues to the Company’s hospitals would have a material adverse effect on the Company’s financial position, results of operations and liquidity.

 

Results of Operations – Continuing Operations

 

Hospital Division

 

Revenues increased 14% to $393 million in the first quarter of 2005 from $343 million in the same period a year ago. Revenue growth resulted primarily from growth in admissions and new hospital development. On a same-store basis, revenues increased 10% in the first quarter of 2005 compared to the same period a year ago.

 

Admissions rose 11% in the first quarter of 2005 compared to the same period a year ago, while patient days rose 3% in the first quarter of 2005 compared to the same period last year. Average length of stay declined to 30 days in the first quarter of 2005 compared to 33 days in the same period a year ago. On a same-store basis, admissions increased 5% in the first quarter of 2005 compared to the same period a year ago, while patient days decreased 2% in the first quarter of 2005 compared to the same period a year ago.

 

Hospital wage and benefit costs of $168 million for the first quarter of 2005 declined 1% from $170 million compared to the same period a year ago. Average hourly wage rates grew 4% for the first quarter of 2005 compared to the same period a year ago. Wage and benefit costs for the first quarter of 2005 were favorably impacted by the Hospital Services Reorganization.

 

Hospital operating income increased 28% to $102 million in the first quarter of 2005 from $79 million in the same period a year ago. Operating margins were 25.9% in the first quarter of 2005 compared to 23.2% in the first quarter of 2004.

 

As previously discussed in Note 5 of the accompanying Notes to Condensed Consolidated Financial Statements, favorable Medicare reimbursement adjustments increased hospital operating income by approximately $3 million in the first quarter of 2005 and $2 million in the first quarter of 2004. In addition, operating income in the first quarter of 2005 was reduced by approximately $4 million in connection with the Hospital Services Reorganization. Excluding these items, growth in hospital operating income in both periods was primarily attributable to growth in admissions (particularly private and commercial admissions) and related operating efficiencies. Aggregate operating costs per admission, including costs associated with the Hospital Services Reorganization, declined 1% in the first quarter of 2005 compared to the same period a year ago.

 

Professional liability costs were $6 million in the first quarter of both 2005 and 2004.

 

Health Services Division

 

Revenues increased 4% to $454 million in the first quarter of 2005 compared to $436 million in the same period a year ago, primarily as a result of increased reimbursement rates. Aggregate revenues per patient day increased 6% in the first quarter of 2005 compared to the same period a year ago. Aggregate patient days

 

25


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Results of Operations – Continuing Operations (Continued)

 

Health Services Division (Continued)

 

declined 2% in the first quarter of 2005 compared to the same period a year ago. Medicare and private patient days declined 5% and 1%, respectively, in the first quarter of 2005 compared to the same period a year ago.

 

Nursing center wage and benefit costs increased 3% to $244 million in the first quarter of 2005 compared to $237 million for the same period a year ago. Average hourly wage rates increased 4% in the first quarter of 2005 compared to the same period a year ago, while employee benefit costs increased 1% for the same periods.

 

Nursing center operating income increased 8% to $53 million in the first quarter of 2005 compared to $49 million in the first quarter of 2004. Operating margins were 11.7% in the first quarter of 2005 compared to 11.2% in the first quarter of 2004. Despite a decline in patient days, nursing center operating income for the first quarter of 2005 improved primarily due to favorable reimbursement rates and operating efficiencies. Growth in overall operating expenses per patient day was slightly less than the rates of growth in revenues per patient day in the first quarter of 2005 compared to the same period last year.

 

Professional liability costs were $16 million in the first quarter of both 2005 and 2004.

 

Rehabilitation Division

 

Revenues increased 23% to $65 million in the first quarter of 2005 from $53 million for the same period a year ago, while operating income increased 14% to $10 million in the first quarter of 2005 from $9 million for the same period a year ago. The increase in revenues in the first quarter of 2005 was primarily attributable to the Hospital Services Reorganization. The increase in operating income in the first quarter of 2005 was primarily attributable to the Hospital Services Reorganization and a decrease in the provision for doubtful accounts. Intercompany revenues for services provided to the Company’s nursing centers totaled $39 million and $36 million in the first quarters of 2005 and 2004, respectively. Intercompany revenues and operating income associated with the Hospital Services Reorganization aggregated $11 million and $1 million, respectively, in the first quarter of 2005.

 

Pharmacy Division

 

Revenues increased 35% to $108 million in the first quarter of 2005 compared to $80 million for the same period a year ago. Revenues associated with the Hospital Services Reorganization aggregated $10 million in the first quarter of 2005. In addition, the increase in revenues in the first quarter of 2005 resulted from growth in the number of non-affiliated customers, price increases and the PPI Acquisition on March 2, 2005. At March 31, 2005, the Company provided pharmacy services to nursing centers containing 75,800 licensed beds, including 29,100 licensed beds that it operates. At March 31, 2004, the Company provided pharmacy services to nursing centers containing 63,300 licensed beds, including 28,200 licensed beds that it operates. Revenues associated with the PPI Acquisition totaled $3 million in the first quarter of 2005.

 

Pharmacy operating income increased 51% to $11 million in the first quarter of 2005 from $8 million in the same period a year ago. Operating income associated with the Hospital Services Reorganization aggregated $2 million in the first quarter of 2005. Operating margins were 10.6% in the first quarter of 2005 compared to 9.5% for the same period a year ago. The cost of goods sold as a percentage of institutional pharmacy revenues was 64.6% in the first quarter of 2005 compared to 64.7% for the same period a year ago. Aggregate pharmacy operating margins improved compared to the same period last year primarily due to administrative cost efficiencies associated with volume growth and the favorable impact of the Hospital Services Reorganization.

 

26


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Results of Operations – Continuing Operations (Continued)

 

Corporate Overhead

 

Operating income for the Company’s operating divisions excludes allocations of corporate overhead. These costs aggregated $29 million in the first quarter of 2005 compared to $27 million for the same period a year ago. As a percentage of consolidated revenues, corporate overhead totaled 3.1% in the first quarter of both 2005 and 2004.

 

Corporate expenses included the operating losses of the Company’s limited purpose insurance subsidiary of $2 million in the first quarter of both 2005 and 2004.

 

Reorganization Items

 

Operating results for the first quarter of 2005 included income of $1.4 million resulting from changes in estimates for accrued professional and administrative costs in connection with the completion of legal proceedings related to the Plan of Reorganization in March 2005.

 

Capital Costs

 

Rent expense increased 7% to $68 million in the first quarter of 2005 compared to $64 million for the same period a year ago. A substantial portion of the increase resulted from contractual inflation increases, including those associated with the Master Lease Agreements, and growth in the number of hospitals operated by the Company.

 

Depreciation and amortization expense increased 12% to $24 million in the first quarter of 2005 compared to $21 million for the same period a year ago. The increase was primarily a result of the Company’s ongoing capital expenditure program.

 

Interest expense declined to $2 million in the first quarter of 2005 compared to $3 million for the same period a year ago. The decline was primarily a result of the repayment of long-term debt in 2004.

 

Investment income, related primarily to the Company’s excess cash balances and insurance subsidiary investments, approximated $2 million in the first quarter of 2005 compared to $1 million for the same period a year ago.

 

Consolidated Results

 

Income from continuing operations before income taxes increased 90% to $54 million for the first quarter of 2005 compared to $29 million for the same period a year ago. Income from continuing operations in the first quarter of 2005 increased 95% to $32 million compared to $17 million for the same period a year ago.

 

Discontinued Operations

 

Net income from discontinued operations aggregated $5 million in the first quarter of 2005 compared to a net loss of $3 million for the same period a year ago. Net income from discontinued operations in the first quarter of 2005 included a favorable pretax adjustment of approximately $10 million ($6 million net of income taxes) resulting from a change in estimate for professional liability reserves related to the Company’s former nursing centers in Florida and Texas. See Notes 2 and 8 of the accompanying Notes to Condensed Consolidated Financial Statements.

 

27


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Liquidity

 

Cash flows provided by operations (including discontinued operations) aggregated $18 million for the three months ended March 31, 2005 compared to cash flows used in operations of $24 million for the same period a year ago. During both periods, the Company maintained sufficient liquidity to fund its ongoing capital expenditure program and, in the first quarter of 2005, finance acquisitions.

 

Cash and cash equivalents totaled $16 million at March 31, 2005 compared to $69 million at December 31, 2004. Based upon existing cash levels, expected operating cash flows and capital spending, and the availability of borrowings under the Company’s revolving credit facility, management believes that the Company has the necessary financial resources to satisfy expected short-term and long-term liquidity needs.

 

Long-term debt at March 31, 2005 aggregated $56 million (including $25 million of borrowings under the Company’s revolving credit facility). Excluding future acquisitions, the Company expects that operating cash flows over the remainder of 2005 will be sufficient to repay all outstanding revolving credit borrowings existing at March 31, 2005. The Company was in compliance with the terms of its revolving credit facility at March 31, 2005.

 

Capital Resources

 

Excluding acquisitions, capital expenditures totaled $18 million in the first quarter of both 2005 and 2004. Capital expenditures (excluding acquisitions) could approximate $120 million to $130 million in 2005. Management believes that its capital expenditure program is adequate to improve and equip existing facilities and complete its construction in progress. The Company’s capital expenditure program is financed generally through the use of operating cash flows. At March 31, 2005, the estimated cost to complete and equip construction in progress approximated $48 million.

 

In the first quarter of 2005, the Company completed the PPI Acquisition at a cost of $28 million and funded a deposit of $32 million related to the SCP Acquisition. The Company financed these two pharmacy acquisitions through the use of operating cash flows and the Company’s revolving credit facility.

 

The terms of the revolving credit facility include certain covenants which limit the Company’s acquisitions and annual capital expenditures.

 

Other Information

 

Effects of Inflation and Changing Prices

 

The Company derives a substantial portion of its revenues from the Medicare and Medicaid programs. Congress and certain state legislatures have enacted or may enact additional significant cost containment measures limiting the Company’s ability to recover its cost increases through increased pricing of its healthcare services. Medicare revenues in the Company’s long-term acute care hospitals and nursing centers are subject to fixed payments under the Medicare prospective payment systems. Medicaid reimbursement rates in many states in which the Company operates nursing centers also are based on fixed payment systems. Generally, these rates are adjusted annually for inflation. However, these adjustments may not reflect the actual increase in the costs of providing healthcare services.

 

Medicare payments to the Company’s nursing centers are based upon certain RUGs payment rates developed by CMS that provide various levels of reimbursement based upon patient acuity. These payment rates could be reduced in the future and may result in a substantial reduction in nursing center revenues and operating margins. The 20% upward adjustment in the payment rates for the care of higher acuity patients under the BBRA

 

28


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Other Information (Continued)

 

Effects of Inflation and Changing Prices (Continued)

 

will remain in effect until a revised RUGs payment system is established by CMS. The Administration previously announced that it will delay the establishment of a revised RUG classification system until 2005. On February 7, 2005, the Administration released its budget proposal for fiscal year 2006, proposing, among other things, to proceed with the refinement of the RUGs payment system. The proposed budget estimates that RUGs refinement will result in an annual savings to Medicare of approximately $1.5 billion in fiscal year 2006 and $10.1 billion over five years. The Administration has not yet proposed a regulation to implement RUGs refinement and the Company cannot anticipate when RUGs refinement may be implemented. Nursing center revenues associated with the 20% upward adjustment approximated $10 million in the first quarter of both 2005 and 2004. Nursing center revenues associated with the 20% upward adjustment approximated $39 million, $36 million, and $33 million for the years ended December 31, 2004, 2003, and 2002, respectively.

 

Most of the Company’s hospitals have been operating under LTAC PPS since September 1, 2003. Operating results under this system are subject to changes in patient acuity and expense levels in the Company’s hospitals. These factors, among others, are subject to significant change. Slight variations in patient acuity could significantly change Medicare revenues generated under LTAC PPS. In addition, the Company’s hospitals may not be able to appropriately adjust their operating costs as patient acuity levels change. Under this system, Medicare reimbursements to the Company’s hospitals are based on a fixed payment system. Operating margins in the hospital division could be negatively impacted if the Company is unable to control its operating costs. As a result of these uncertainties, the Company cannot predict the ultimate long-term impact of LTAC PPS on its hospital operating results and the Company can make no assurances that such regulations or operational changes resulting from these regulations will not have a material adverse impact on its financial position, results of operations or liquidity. In addition, the Company can make no assurances that LTAC PPS will not have a material adverse effect on revenues from private and commercial third party payors. Various factors, including a reduction in average length of stay, have had a negative impact on revenues from private and commercial third party payors.

 

In addition, CMS recently issued proposed rules that could result in a material reduction in Medicare payments to the Company’s hospitals. On April 25, 2005, CMS published the proposed updates to the weights for DRGs and the geometric length-of-stay thresholds that are scheduled to take effect for Medicare discharges under LTAC PPS occurring on or after October 1, 2005. CMS has estimated that these proposed changes would result in an aggregate reduction in payments to long-term acute care hospitals of approximately 4.7%. Based upon its recent historical discharges, the Company has estimated that the impact of these proposed changes could reduce Medicare revenues to the Company’s hospitals between $35 million to $40 million on an annualized basis. These proposed rules are subject to a 60-day comment period. If the proposed rules were implemented, the potential reduction in Medicare revenues to the Company’s hospitals would have a material adverse effect on the Company’s financial position, results of operations and liquidity.

 

In January 2005, CMS issued final regulations on Medicare Part D which will be effective on January 1, 2006. Medicare beneficiaries who also are entitled to benefits under a state Medicaid program (so-called “dual eligibles”) will have their outpatient prescription drug costs covered by the new Medicare drug benefit, subject to certain limitations. Most of the nursing center residents that the Company serves whose drug costs are currently covered by state Medicaid programs are dual eligibles who will qualify for the new Medicare drug benefit. Accordingly, Medicaid will no longer be a payor for the pharmacy services provided to these residents.

 

The Company continues to review the final Medicare Part D regulations but it cannot assess the overall impact of MMA on its institutional pharmacy business. The impact of this legislation depends upon a variety of factors, including the sub-regulatory guidance from CMS, the Company’s ultimate relationships with the private

 

29


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Other Information (Continued)

 

Effects of Inflation and Changing Prices (Continued)

 

prescription drug plans which will provide coverage for prescription drugs under Medicare Part D and the patient mix of its customers. This legislation may reduce revenue and impose additional costs to the industry. In addition, since CMS may issue additional federal regulations and guidance under MMA, there can be no assurance that MMA and the regulations promulgated under MMA will not have a material adverse effect on the Company’s institutional pharmacy business.

 

Management believes that the Company’s operating margins may continue to be under pressure as the growth in operating expenses, particularly professional liability, labor and employee benefits costs, exceeds payment increases from third party payors. In addition, as a result of competitive pressures, the Company’s ability to maintain operating margins through price increases to private patients is limited.

 

Litigation

 

The Company is a party to certain material litigation. See Note 11 of the accompanying Notes to Condensed Consolidated Financial Statements.

 

30


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Condensed Consolidated Statement of Operations

(Unaudited)

(In thousands, except per share amounts)

 

     2004 Quarters

          First
Quarter
2005


 
     First

    Second

    Third

    Fourth

    Year

   

Revenues

   $ 858,015     $ 885,819     $ 884,254     $ 903,135     $ 3,531,223     $ 939,989  
    


 


 


 


 


 


Salaries, wages and benefits

     484,049       486,542       496,678       494,872       1,962,141       515,020  

Supplies

     115,496       119,442       121,409       122,873       479,220       128,283  

Rent

     63,619       65,121       66,441       66,749       261,930       67,996  

Other operating expenses

     142,321       147,300       145,177       151,431       586,229       152,167  

Depreciation and amortization

     21,561       22,241       22,960       23,476       90,238       24,114  

Interest expense

     3,654       4,713       2,535       1,912       12,814       2,000  

Investment income

     (1,214 )     (1,823 )     (1,603 )     (1,791 )     (6,431 )     (2,348 )
    


 


 


 


 


 


       829,486       843,536       853,597       859,522       3,386,141       887,232  
    


 


 


 


 


 


Income from continuing operations before reorganization items and income taxes

     28,529       42,283       30,657       43,613       145,082       52,757  

Reorganization items

           (304 )                 (304 )     (1,371 )
    


 


 


 


 


 


Income from continuing operations before income taxes

     28,529       42,587       30,657       43,613       145,386       54,128  

Provision for income taxes

     11,996       17,533       12,130       17,804       59,463       21,868  
    


 


 


 


 


 


Income from continuing operations

     16,533       25,054       18,527       25,809       85,923       32,260  

Discontinued operations, net of
income taxes:

                                                

Income (loss) from operations

     (2,693 )     (2,222 )     4,598       796       479       4,630  

Loss on divestiture of operations

           (1,063 )     (7,557 )     (7,202 )     (15,822 )      
    


 


 


 


 


 


Net income

   $ 13,840     $ 21,769     $ 15,568     $ 19,403     $ 70,580     $ 36,890  
    


 


 


 


 


 


Earnings per common share:

                                                

Basic:

                                                

Income from
continuing operations

   $ 0.47     $ 0.70     $ 0.51     $ 0.71     $ 2.40     $ 0.89  

Discontinued operations:

                                                

Income (loss) from operations

     (0.08 )     (0.06 )     0.13       0.02       0.01       0.13  

Loss on divestiture
of operations

           (0.03 )     (0.21 )     (0.20 )     (0.44 )      
    


 


 


 


 


 


Net income

   $ 0.39     $ 0.61     $ 0.43     $ 0.53     $ 1.97     $ 1.02  
    


 


 


 


 


 


Diluted:

                                                

Income from
continuing operations

   $ 0.38     $ 0.60     $ 0.44     $ 0.61     $ 2.03     $ 0.73  

Discontinued operations:

                                                

Income (loss) from operations

     (0.06 )     (0.05 )     0.11       0.02       0.01       0.10  

Loss on divestiture
of operations

           (0.03 )     (0.18 )     (0.17 )     (0.37 )      
    


 


 


 


 


 


Net income

   $ 0.32     $ 0.52     $ 0.37     $ 0.46     $ 1.67     $ 0.83  
    


 


 


 


 


 


Shares used in computing earnings per common share:

                                                

Basic

     35,414       35,536       35,939       36,200       35,774       36,312  

Diluted

     42,721       41,913       42,293       42,639       42,403       44,410  

 

31


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Operating Data

(Unaudited)

(In thousands)

 

    2004 Quarters

         

First

Quarter
2005


 
    First

    Second

    Third

    Fourth

    Year

   

Revenues:

                                               

Hospital division

  $ 343,349     $ 350,097     $ 350,852     $ 354,360     $ 1,398,658     $ 393,040  

Health services division

    435,998       452,820       449,674       462,880       1,801,372       454,047  

Rehabilitation division

    52,699       52,588       61,157  (a)     61,982       228,426       64,947  

Pharmacy division

    79,746       84,346       96,591  (a)     99,352       360,035       107,957  
   


 


 


 


 


 


      911,792       939,851       958,274       978,574       3,788,491       1,019,991  

Eliminations:

                                               

Rehabilitation

    (36,023 )     (36,579 )     (46,642 )(a)     (46,743 )     (165,987 )     (49,545 )

Pharmacy

    (17,754 )     (17,453 )     (27,378 )(a)     (28,696 )     (91,281 )     (30,457 )
   


 


 


 


 


 


      (53,777 )     (54,032 )     (74,020 )     (75,439 )     (257,268 )     (80,002 )
   


 


 


 


 


 


      $858,015     $ 885,819     $ 884,254     $ 903,135     $ 3,531,223     $ 939,989  
   


 


 


 


 


 


Income from continuing operations:

                                               

Operating income (loss):

                                               

Hospital division

  $ 79,687     $ 86,120     $ 79,210  (a)   $ 83,933     $ 328,950     $ 101,801  

Health services division

    48,945       63,001       57,978       67,057       236,981       53,021  

Rehabilitation division

    8,519       7,265       7,737  (a)     7,910       31,431       9,711  

Pharmacy division

    7,609       7,729       10,853  (a)     10,871       37,062       11,454  

Corporate:

                                               

Overhead

    (26,834 )     (30,356 )     (33,028 )     (33,531 )     (123,749 )     (29,115 )

Insurance subsidiary

    (1,777 )     (1,224 )     (1,760 )     (2,281 )     (7,042 )     (2,353 )
   


 


 


 


 


 


      (28,611 )     (31,580 )     (34,788 )     (35,812 )     (130,791 )     (31,468 )
   


 


 


 


 


 


      116,149       132,535       120,990       133,959       503,633       144,519  

Reorganization items

          304                   304       1,371  
   


 


 


 


 


 


Operating income

    116,149       132,839       120,990       133,959       503,937       145,890  

Rent

    (63,619 )     (65,121 )     (66,441 )     (66,749 )     (261,930 )     (67,996 )

Depreciation and amortization

    (21,561 )     (22,241 )     (22,960 )     (23,476 )     (90,238 )     (24,114 )

Interest, net

    (2,440 )     (2,890 )     (932 )     (121 )     (6,383 )     348  
   


 


 


 


 


 


Income from continuing operations before income taxes

    28,529       42,587       30,657       43,613       145,386       54,128  

Provision for income taxes

    11,996       17,533       12,130       17,804       59,463       21,868  
   


 


 


 


 


 


    $ 16,533     $ 25,054     $ 18,527     $ 25,809     $ 85,923     $ 32,260  
   


 


 


 


 


 



(a)   Effective July 1, 2004, the rehabilitation division and pharmacy division began providing services to the Company’s hospital division as a result of the Hospital Services Reorganization. Revenues in the third quarter of 2004 associated with these new arrangements aggregated $10.3 million in the rehabilitation division and $9.4 million in the pharmacy division. These new arrangements reduced hospital division operating income in the third quarter of 2004 by approximately $4.1 million while increasing rehabilitation division operating income by approximately $1.4 million and pharmacy division operating income by approximately $2.1 million.

 

32


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Operating Data (Continued)

(Unaudited)

(In thousands)

 

     2004 Quarters

        First
Quarter
2005


     First

   Second

   Third

   Fourth

   Year

  

Rent:

                                         

Hospital division

   $ 22,488    $ 23,168    $ 23,898    $ 24,077    $ 93,631    $ 24,717

Health services division

     39,799      40,398      40,923      41,064      162,184      41,486

Rehabilitation division

     611      708      747      773      2,839      800

Pharmacy division

     662      790      812      780      3,044      926

Corporate

     59      57      61      55      232      67
    

  

  

  

  

  

       $63,619    $ 65,121    $ 66,441    $ 66,749    $ 261,930    $ 67,996
    

  

  

  

  

  

Depreciation and amortization:

                                         

Hospital division

   $ 8,257    $ 8,496    $ 8,923    $ 9,401    $ 35,077    $ 9,554

Health services division

     6,615      6,796      6,901      7,290      27,602      7,822

Rehabilitation division

     33      37      38      51      159      54

Pharmacy division

     530      583      603      718      2,434      926

Corporate

     6,126      6,329      6,495      6,016      24,966      5,758
    

  

  

  

  

  

       $21,561    $ 22,241    $ 22,960    $ 23,476    $ 90,238    $ 24,114
    

  

  

  

  

  

Capital expenditures, excluding acquisitions (including discontinued operations):

                                         

Hospital division

   $ 5,406    $ 5,177    $ 8,867    $ 10,697    $ 30,147    $ 8,235

Health services division

     8,450      6,487      7,074      14,692      36,703      6,957

Rehabilitation division

     47      56      19      246      368      2

Pharmacy division

     773      1,075      1,004      1,977      4,829      1,075

Corporate:

                                         

Information systems

     2,651      4,033      4,251      4,892      15,827      1,462

Other

     554      829      1,175      1,956      4,514      232
    

  

  

  

  

  

     $ 17,881    $ 17,657    $ 22,390    $ 34,460    $ 92,388    $ 17,963
    

  

  

  

  

  

 

33


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Operating Data (Continued)

(Unaudited)

 

     2004 Quarters

        First
Quarter
2005


     First

   Second

   Third

   Fourth

   Year

  

Hospital data:

                                         

End of period data:

                                         

Number of hospitals

     66      68      72      72             73

Number of licensed beds

     5,245      5,396      5,569      5,569             5,603

Revenue mix % (a):

                                         

Medicare

     67      64      63      63      65      65

Medicaid

     7      8      8      7      7      6

Private and other

     26      28      29      30      28      29

Admissions:

                                         

Medicare

     6,780      6,674      6,550      6,719      26,723      7,397

Medicaid

     682      789      763      741      2,975      727

Private and other

     1,243      1,401      1,369      1,495      5,508      1,564
    

  

  

  

  

  

       8,705      8,864      8,682      8,955      35,206      9,688
    

  

  

  

  

  

Admissions mix %:

                                         

Medicare

     78      75      75      75      76      76

Medicaid

     8      9      9      8      8      8

Private and other

     14      16      16      17      16      16

Patient days:

                                         

Medicare

     206,256      200,628      190,466      190,772      788,122      207,670

Medicaid

     27,670      29,228      30,435      30,200      117,533      26,660

Private and other

     51,856      52,640      53,571      56,160      214,227      61,052
    

  

  

  

  

  

       285,782      282,496      274,472      277,132      1,119,882      295,382
    

  

  

  

  

  

Average length of stay:

                                         

Medicare

     30.4      30.1      29.1      28.4      29.5      28.1

Medicaid

     40.6      37.0      39.9      40.8      39.5      36.7

Private and other

     41.7      37.6      39.1      37.6      38.9      39.0

Weighted average

     32.8      31.9      31.6      30.9      31.8      30.5

Revenues per admission (a):

                                         

Medicare

   $ 33,722    $ 33,902    $ 33,963    $ 33,466    $ 33,762    $ 34,750

Medicaid

     34,701      34,102      35,889      33,155      34,462      30,295

Private and other

     73,248      69,184      73,784      70,188      71,517      72,872

Weighted average

     39,443      39,497      40,411      39,571      39,728      40,570

Revenues per patient day (a):

                                         

Medicare

   $ 1,109    $ 1,128    $ 1,168    $ 1,179    $ 1,145    $ 1,238

Medicaid

     855      921      900      814      872      826

Private and other

     1,756      1,841      1,886      1,868      1,839      1,867

Weighted average

     1,202      1,239      1,278      1,279      1,249      1,331

Medicare case mix index
(discharged patients only)

     1.26      1.25      1.21      1.19      1.23      1.22

Average daily census

     3,140      3,104      2,983      3,012      3,060      3,282

Occupancy %

     63.1      60.7      57.0      56.3      59.2      61.2

(a)   Includes income of $2.9 million in the first quarter of 2005, $2.2 million in the first quarter of 2004, $3.9 million in the second quarter of 2004 and $1.6 million in the third quarter of 2004 related to certain Medicare reimbursement issues.

 

34


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Operating Data (Continued)

(Unaudited)

 

     2004 Quarters

        First
Quarter
2005


     First

   Second

    Third

   Fourth

   Year

  

Nursing center data:

                                          

End of period data:

                                          

Number of nursing centers:

                                          

Owned or leased

     242      242       242      242             242

Managed

     7      7       7      7             7
    

  


 

  

         

       249      249       249      249             249
    

  


 

  

         

Number of licensed beds:

                                          

Owned or leased

     31,193      31,189       31,170      31,170             31,170

Managed

     803      803       803      803             803
    

  


 

  

         

       31,996      31,992       31,973      31,973             31,973
    

  


 

  

         

Revenue mix %:

                                          

Medicare

     36      33       32      32      33      34

Medicaid

     46      49  (a)     50      50      49      48

Private and other

     18      18       18      18      18      18

Patient days (excludes managed facilities):

                                          

Medicare

     423,649      400,487       377,563      380,782      1,582,481      402,845

Medicaid

     1,642,585      1,657,812       1,701,837      1,684,972      6,687,206      1,616,789

Private and other

     396,408      399,321       404,823      410,171      1,610,723      393,593
    

  


 

  

  

  

       2,462,642      2,457,620       2,484,223      2,475,925      9,880,410      2,413,227
    

  


 

  

  

  

Patient day mix %:

                                          

Medicare

     17      16       15      15      16      17

Medicaid

     67      68       69      68      68      67

Private and other

     16      16       16      17      16      16

Revenues per patient day:

                                          

Medicare Part A

   $ 331    $ 331     $ 336    $ 345    $ 336    $ 348

Total Medicare
(including Part B)

     373      376       386      394      382      389

Medicaid

     121      134  (a)     132      137      131      134

Private and other

     198      200       197      198      198      206

Weighted average

     177      184       181      187      182      188

Average daily census

     27,062      27,007       27,002      26,912      26,996      26,814

Occupancy %

     86.4      86.3       86.2      86.0      86.2      85.7

Rehabilitation data:

                                          

Revenue mix %:

                                          

Company-operated

     70      71       76      75      73      76

Non-affiliated

     30      29       24      25      27      24

Pharmacy data:

                                          

Number of customer licensed beds at end of period:

                                          

Company-operated

     28,188      28,164       28,476      28,634             29,105

Non-affiliated

     35,102      36,385       36,671      37,561             46,745
    

  


 

  

         

       63,290      64,549       65,147      66,195             75,850
    

  


 

  

         


(a)   Includes income of $4.5 million related to prior year North Carolina provider tax program revenues recorded in the second quarter. Prior year provider tax expense of $1.5 million related to this program was recorded in other operating expenses.

 

35


Table of Contents

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The following discussion of the Company’s exposure to market risk contains “forward-looking statements” that involve risks and uncertainties. The information presented has been prepared utilizing certain assumptions considered reasonable in light of information currently available to the Company. Given the unpredictability of interest rates as well as other factors, actual results could differ materially from those projected in such forward-looking information.

 

The Company’s exposure to market risk relates to changes in the prime rate, federal funds rate and the London Interbank Offered Rate which affect the interest paid on certain borrowings.

 

The following table provides information about the Company’s financial instruments that are sensitive to changes in interest rates. The table presents principal cash flows and related weighted average interest rates by expected maturity date.

 

Interest Rate Sensitivity

Principal (Notional) Amount by Expected Maturity

Average Interest Rate

(Dollars in thousands)

 

     Expected maturities

  

Fair
value

3/31/05


     2005

    2006

    2007

    2008

    2009

    Thereafter

    Total

  

Liabilities:

                                                             

Long-term debt, including amounts due within one year:

                                                             

Fixed rate:

                                                             

Ventas debt obligation:

                                                             

Principal

   $ 4,017     $ 6,154     $ 7,209     $ 5,510     $ 4,889     $ 7,754     $ 35,533    $ 35,533

Interest

     2,726       3,082       2,350       1,612       1,096       1,262       12,128     
    


 


 


 


 


 


 

  

       6,743       9,236       9,559       7,122       5,985       9,016       47,661      35,533

Other

     49       67       71       76       81       733       1,077      1,047
    


 


 


 


 


 


 

  

     $ 6,792     $ 9,303     $ 9,630     $ 7,198     $ 6,066     $ 9,749     $ 48,738    $ 36,580
    


 


 


 


 


 


 

  

Average interest rate

     10.9 %     10.9 %     11.0 %     10.9 %     10.9 %     10.6 %             

Variable rate (a)

   $     $     $     $     $ 25,200     $     $ 25,200    $ 25,200

(a)   Interest on borrowings under the Company’s revolving credit facility is payable, at the Company’s option, at (1) the London Interbank Offered Rate plus an applicable margin ranging from 2.00% to 2.75% or (2) prime plus an applicable margin ranging from 1.00% to 1.75%. The applicable margin is based on the Company’s adjusted leverage ratio as defined in the Company’s revolving credit facility.

 

36


Table of Contents

ITEM 4.    CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures and Changes in Internal Control Over Financial Reporting

 

The Company has carried out an evaluation under the supervision and with the participation of management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2005, the Company’s disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed in the reports that the Company files and submits under the Exchange Act is recorded, processed, summarized and reported as and when required.

 

There has been no change in the Company’s internal control over financial reporting during the Company’s quarter ended March 31, 2005, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

37


Table of Contents

PART II.    OTHER INFORMATION

 

Item  1.    Legal Proceedings

 

Summary descriptions of various significant litigation follow.

 

A shareholder derivative suit entitled Thomas G. White on behalf of Vencor, Inc. and Ventas, Inc. v. W. Bruce Lunsford, et al., Case No. 98CI03669, was filed on July 2, 1998 in the Jefferson County, Kentucky, Circuit Court. The suit was brought on behalf of the Company and Ventas against certain former executive officers and directors of the Company and Ventas. The complaint alleges that the defendants damaged the Company and Ventas by engaging in violations of the securities laws, engaging in insider trading, fraud and securities fraud and damaging the reputation of the Company and Ventas. The plaintiff asserts that such actions were taken deliberately, in bad faith and constitute breaches of the defendants’ duties of loyalty and due care. The complaint alleges that certain of the Company’s and Ventas’s former executive officers during a specified time frame violated Sections 10(b) and 20(a) of the Exchange Act, by, among other things, issuing to the investing public a series of false and misleading statements concerning Ventas’s then current operations and the inherent value of its common stock. The complaint further alleges that as a result of these purported false and misleading statements concerning Ventas’s revenues and successful acquisitions, the price of its common stock was artificially inflated. In particular, the complaint alleges that the defendants issued false and misleading financial statements during the first, second and third calendar quarters of 1997 which misrepresented and understated the impact that changes in Medicare reimbursement policies would have on Ventas’s core services and profitability. The complaint further alleges that the defendants issued a series of materially false statements concerning the purportedly successful integration of Ventas’s acquisitions and prospective earnings per share for 1997 and 1998, which the defendants knew lacked any reasonable basis and were not being achieved. The suit seeks unspecified damages, interest, punitive damages, reasonable attorneys’ fees, expert witness fees and other costs, and any extraordinary equitable and/or injunctive relief permitted by law or equity to assure that the Company and Ventas have an effective remedy. In October 2002, the defendants filed a motion to dismiss for failure to prosecute the case. The court granted the motion to dismiss but the plaintiff subsequently moved the court to vacate the dismissal. The defendants filed an opposition to the plaintiff’s motion to vacate the dismissal, but in August 2003 the court reinstated the lawsuit. In September 2003, the Company filed a renewed motion to dismiss, as to all defendants, based on the plaintiff’s failure to make a demand for remedy upon the appropriate board of directors. The Company also has argued that it is an improper party to this lawsuit. In March 2004, the judge who had been presiding over this lawsuit recused himself because of a possible conflict of interest. The case was then assigned to another judge, who issued an order on July 29, 2004, vacating the previous judge’s denial of the defendants’ motion to dismiss. The parties completed their briefing on the renewed motion to dismiss in January 2005 and are awaiting the court’s ruling on that motion. The Company believes that the allegations in the complaint are without merit and intends to defend this action vigorously.

 

The Company is a party to various legal actions (some of which are not insured), and regulatory and other government investigations and sanctions arising in the ordinary course of its business. The Company is unable to predict the ultimate outcome of pending litigation and regulatory and other government investigations. In addition, there can be no assurance that the DOJ, CMS or other federal and state enforcement and regulatory agencies will not initiate additional investigations related to the Company’s businesses in the future, nor can there be any assurance that the resolution of any litigation or investigations, either individually or in the aggregate, would not have a material adverse effect on the Company’s financial position, results of operations and liquidity.

 

38


Table of Contents

PART II.    OTHER INFORMATION (Continued)

 

Item 6. Exhibits
      
    10.1   

Amendment No. 2 to the Kindred 401(k) Plan dated as of March 8, 2005.

    10.2   

Amendment No. 2 to the Kindred & Affiliates 401(k) Plan dated March 8, 2005.

    31   

Rule 13a-14(a)/15d-14(a) Certifications.

    32   

Section 1350 Certifications.

 

39


Table of Contents

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

        KINDRED HEALTHCARE, INC.
Date: May 4, 2005      

/s/    PAUL J. DIAZ        


       

Paul J. Diaz

President and

Chief Executive Officer

Date: May 4, 2005      

/s/    RICHARD A. LECHLEITER        


       

Richard A. Lechleiter

Executive Vice President and

Chief Financial Officer

 

40